CRT 2026
Coronary
Robert-Jan M. van Geuns, MD, PhD
Cardiologist
RadboudUMC
Nijmegen, Gelderland, Netherlands
Disclosure(s): Abbott Vascular,: Grant/Research Support (Ongoing); InfraRedx: Grant/Research Support (Terminated, February 24, 2026), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, February 24, 2026)
Lorenzo Azzalini, MD, PhD, MSc
Interventional Cardiologist
University of Washington
Seattle, Washington, United States
Disclosure(s): Dr. Azzalini received consulting fees from Teleflex, Abiomed, GE Healthcare, Reflow Medical, Shockwave Medical, Abbott, Boston Scientific, XyloCor Therapeutics, HeartFlow, and Cardiovascular Systems, Inc.; and owns equity in Reflow Medical.: Consulting Fees (e.g., advisory boards) (Ongoing)
Suhail Dohad, MD
Medical director of aortic and ischemic limb disease. Director of complex PCI/Endovascular fellowship
Cedars Sinai Medical Center
Beverly Hills, California, United States
Disclosure(s): No financial relationships to disclose
Khaldoon Alaswad, MD, FACC, FSCAI
Director, Catheterization Laboratory
Henry Ford Hospital and Health System
Detroit, Michigan, United States
Disclosure(s): No financial relationships to disclose
Sandeep Basavarajaiah, MBBS, MD, MRCP, FESC
Consultant Cardiologist
National Health Service
Disclosure(s): No financial relationships to disclose
Farouc A. Jaffer, MD, PhD
Director Coronary Intervention and CTO PCI Program, Professor of Medicine
Massachusetts General Hospital / Harvard Medical School
Boston, Massachusetts, United States
Disclosure(s): Boston Scientific, Siemens, Magenta Medical, Philips, Biotronik, Mercator, Terumo, Abiomed, Shockwave, DurVena, i3, Medtronic, FastWave;: Consulting Fees (e.g., advisory boards) (Ongoing); Canon, Siemens, Shockwave, Teleflex, Mercator, Boston Scientific, HeartFlow, Neovasc; Orbus Neich: Grant/Research Support (Ongoing); Fastwave: Stock-privately held company (Ongoing); i3: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)
Jaikirshan Khatri, MD
Director of Cardiac Catheterization Laboratory
Weill Cornell Medical Center, United States
Disclosure(s): Siemens, Neovasc/Shockwave, Teleflex, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Michael Megaly, MD
Interventional cardiologist
Integris Health Heart Hospital
Oklahoma City, Oklahoma, United States
Disclosure(s): No financial relationships to disclose
Srini Potluri, MD
Chief of Cardiology
Baylor Scott and White The Heart Hospital Plano
Frisco, Texas, United States
Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Stephane Rinfret, MD, SM
Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States
Disclosure(s): SIS Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Gerald S. Werner, MD, PhD, FSCAI
Senior Consultant CTO
University Heart Center Frankfurt/Main
Frankfurt am Main, Hessen, Germany
Disclosure(s): No financial relationships to disclose